Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249

Article  PubMed  Google Scholar 

Oonk MHM, Planchamp F, Baldwin P, Bidzinski M, Brännström M, Landoni F et al (2017) European Society of Gynecological Oncology guidelines for the management of patients with vulvar cancer. Int J Gynecol Cancer 27(4):832–837

Article  PubMed  Google Scholar 

Olawaiye AB, Cuello MA, Rogers LJ (2021) Cancer of the vulva: 2021 update. Int J Gynecol Obstet 155(S1):7–18

Article  Google Scholar 

Moore DH, Ali S, Koh WJ, Michael H, Barnes MN, McCourt CK et al (2012) A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally advanced squamous cell carcinoma of the vulva: a gynecologic oncology group study. Gynecol Oncol 124(3):529–533

Article  CAS  PubMed  Google Scholar 

Gaffney DK, King B, Viswanathan AN, Barkati M, Beriwal S, Eifel P et al (2016) Consensus recommendations for radiation therapy contouring and treatment of vulvar carcinoma. Int J Radiat Oncol 95(4):1191–1200

Article  Google Scholar 

U.S. Department of Health and Human Services (2017) Common Terminology Criteria for Adverse Events (CTCAE) (Version 5.0). National Cancer Institute. Available at: https://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm

Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R et al (2009) New response evaluation criteria in solid tumors: revised RECIST guideline (version 1.1). Eur J Cancer. 45(2):228–47

Article  CAS  PubMed  Google Scholar 

Kaur S, Garg H, Nandwani M (2022) The unmet needs in the management of vulvar cancer and a review of Indian literature. JCO Glob Oncol 8:e2200197

Article  PubMed  PubMed Central  Google Scholar 

Bruni L, Albero G, Serrano B, Mena M, Collado JJ, Gómez D, Muñoz J, Bosch FX, de Sanjosé S (2023) ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in India. Summary Report 10 March 2023. Available at: https://hpvcentre.net/statistics/reports/IND.pdf

Singareddy R, Bajwa H, Alluri K, Raju KVVN, Rao TS, Rajeev G (2019) Carcinoma vulva patterns of recurrence and treatment outcomes: a single-institution experience. J Cancer Res Ther. 15(6):1328

Article  PubMed  Google Scholar 

Kim Y, Kim JY, Kim JY, Lee NK, Kim JH, Kim YB et al (2015) Treatment outcomes of curative radiotherapy in patients with vulvar cancer: results of the retrospective KROG 1203 study. Radiat Oncol J 33(3):198

Article  PubMed  PubMed Central  Google Scholar 

Mazumder K, Elangovan A, Rai B, Suri V, Jain V, Kalra J et al (2019) Conventional radiotherapy and intensity-modulated radiotherapy in carcinoma vulva: an experience from a tertiary medical center of India. South Asian J Cancer 08(01):41–43

Article  Google Scholar 

Poddar P, Patel S, Arora R, Parekh C, Dave P, Amin S (2020) Prognostic value of lymph node ratio in surgically treated cases of vulvar cancer: a tertiary care center experience. Obstet Gynecol Sci 63(2):158–163

Article  PubMed  PubMed Central  Google Scholar 

Te Grootenhuis NC, Pouwer AW, De Bock GH, Hollema H, Bulten J, Van Der Zee AGJ et al (2019) Margin status revisited in vulvar squamous cell carcinoma. Gynecol Oncol 154(2):266–275

Article  Google Scholar 

Oonk MHM, Planchamp F, Baldwin P, Mahner S, Mirza MR, Fischerová D et al (2023) European Society of Gynecological Oncology guidelines for the management of patients with vulvar cancer - update 2023. Int J Gynecol Cancer 33(7):1023–1043

Article  PubMed  PubMed Central  Google Scholar 

Chapman BV, Gill BS, Viswanathan AN, Balasubramani GK, Sukumvanich P, Beriwal S (2017) Adjuvant radiation therapy for margin-positive vulvar squamous cell carcinoma: defining the ideal dose-response using the National Cancer Data Base. Int J Radiat Oncol 97(1):107–117

Article  Google Scholar 

Gill BS, Bernard ME, Lin JF, Balasubramani GK, Rajagopalan MS, Sukumvanich P et al (2015) Impact of adjuvant chemotherapy with radiation for node-positive vulvar cancer: a National Cancer Data Base (NCDB) analysis. Gynecol Oncol 137(3):365–372

Article  PubMed  Google Scholar 

Rao YJ, Chundury A, Schwarz JK, Hassanzadeh C, DeWees T, Mullen D et al (2017) Intensity modulated radiation therapy for squamous cell carcinoma of the vulva: treatment technique and outcomes. Adv Radiat Oncol 2(2):148–158

Article  PubMed  PubMed Central  Google Scholar 

Van Doorn HC, Ansink A, Verhaar-Langereis MM, Stalpers LL. Neoadjuvant chemoradiation for advanced primary vulvar cancer. In: The Cochrane Collaboration, editor. Cochrane Database of Systematic Reviews [Internet]. Chichester, UK: John Wiley & Sons, Ltd; 2006 [cited 2023 Aug 29]. p. CD003752.pub2. https://doi.org/10.1002/14651858.CD003752.pub2

Kortekaas KE, Bastiaannet E, van Doorn HC, van Steenwijk PJ, Ewing-Graham PC, Creutzberg CL et al (2020) Vulvar cancer subclassification by HPV and p53 status results in three clinically distinct subtypes. Gynecol Oncol. 159(3):649–56

Article  CAS  PubMed  Google Scholar